2022 Frontiers in Neuroscience

/in , , , , /by

2022 Frontiers in Neuroscience:

 

ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease

2022 AAIC Poster

/in , , , /by

2022 AAIC Poster:

 

Preparation and qualification of soluble AβOs for use in bioanalytical assays supporting AD therapeutics.

2022 CTAD Poster

/in , , , , /by

2022 CTAD Poster:

 

Critical evaluation and comparison of biomarker values in commercial CSF with Lumipulse® to support assay development for clinical trials.